| Bioactivity | Enavermotide (UCP2) is an immunological agent for active immunization (antineoplastic)[1]. |
| Name | Enavermotide |
| CAS | 524060-93-3 |
| Sequence | Lys-Ser-Val-Trp-Ser-Lys-Leu-Gln-Ser-Ile-Gly-Ile-Arg-Gln-His |
| Shortening | KSVWSKLQSIGIRQH |
| Formula | C79H131N25O21 |
| Molar Mass | 1767.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Godet Y, et al. Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response. Clin Cancer Res. 2012 May 15;18(10):2943-53. |